Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Soleno Therapeutics Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 76 | 98 | +22 |
| Shares | 31.4M | 35.5M | +4.13M (+13.1%) |
| Value | $1.26B | $1.52B | +$255.3M (+20.2%) |
New holders (32)
Institutions that held Soleno Therapeutics Inc at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (10)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Silverarc Capital Management, LLC | 73,665 | $2.97M |
| J. Goldman & Co LP | 73,252 | $2.95M |
| Cubist Systematic Strategies, LLC | 57,006 | $2.29M |
| Dimensional Fund Advisors LP | 20,754 | $835.3K |
| AWM Investment Company, Inc. | 20,000 | $805.0K |
| Bank of New York Mellon Corp | 9,936 | $399.9K |
| Atom Investors LP | 8,846 | $356.1K |
| Engineers Gate Manager LP | 7,702 | $310.0K |
| Captrust Financial Advisors | 6,058 | $243.8K |
| Simplex Trading, LLC | 4,192 | $168.0K |